Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets

B Chen, P Yu, WN Chan, F Xie, Y Zhang… - … and Targeted Therapy, 2024 - nature.com
Zinc metabolism at the cellular level is critical for many biological processes in the body. A
key observation is the disruption of cellular homeostasis, often coinciding with disease …

Molecular genetics of prostate cancer: new prospects for old challenges

MM Shen, C Abate-Shen - Genes & development, 2010 - genesdev.cshlp.org
Despite much recent progress, prostate cancer continues to represent a major cause of
cancer-related mortality and morbidity in men. Since early studies on the role of the …

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

CW Kinkade, M Castillo-Martin… - The Journal of …, 2008 - Am Soc Clin Investig
The AKT/mammalian target of rapamycin (AKT/mTOR) and ERK MAPK signaling pathways
have been shown to cooperate in prostate cancer progression and the transition to …

Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice

V Fritz, Z Benfodda, G Rodier, C Henriquet… - Molecular cancer …, 2010 - AACR
Increased de novo fatty acid (FA) synthesis is one hallmark of tumor cells, including prostate
cancer. We present here our most recent results showing that lipid composition in human …

Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway

TM Morgan, TD Koreckij, E Corey - Current cancer drug targets, 2009 - ingentaconnect.com
A large number of novel therapeutics is currently undergoing clinical evaluation for the
treatment of prostate cancer, and small molecule signal transduction inhibitors are a …

Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition

A Rasola, M Sciacovelli, F Chiara… - Proceedings of the …, 2010 - National Acad Sciences
We studied human cancer cell models in which we detected constitutive activation of ERK. A
fraction of active ERK was found to be located in mitochondria in RWPE-2 cells, obtained by …

Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management

VM Adhami, DN Syed, N Khan, H Mukhtar - Biochemical pharmacology, 2012 - Elsevier
Epidemiologic and case control population based studies over the past few decades have
identified diet as an important determinant of cancer risk. This evidence has kindled interest …

Inorganic arsenic and human prostate cancer

L Benbrahim-Tallaa, MP Waalkes - Environmental health …, 2008 - ehp.niehs.nih.gov
Objective We critically evaluated the etiologic role of inorganic arsenic in human prostate
cancer. Data sources We assessed data from relevant epidemiologic studies concerning …

Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization

D Gioeli, BE Black, V Gordon, A Spencer… - Molecular …, 2006 - academic.oup.com
Activation of signal transduction kinase cascades is known to alter androgen receptor (AR)
activity, but the molecular mechanisms are still poorly defined. Here we show that stress …

Post-translational modification of the androgen receptor

D Gioeli, BM Paschal - Molecular and cellular endocrinology, 2012 - Elsevier
Regulation of the androgen receptor (AR) by its cognate ligand is well established, but how
post-translational modification modulates AR activity is only emerging. The AR is subject to …